Document RJ330bV5KOYpm0DDgeDmn5b4E

A COMPARISON OF FOUR MOUSE STRAINS EXPOSED TO SUBCHRONICALLY INHALED VINYLIDENE CHLORIDE (VDC) By: J. W. Henck, J. F. Quast and L. W. Rampy January 12, 1979 Dov Chemical USA Toxicology Research Laboratory Health & Environmental Science 1S03 Building Midland, Michigan 48640 SL 068127 SUMMARY To determine the affect of inhaled vinylldena chloride (VDC) on four different laboratory mouse strains, male and female Ha(ICS) mica, B6C3F1 mice, CD-1 mice, and CIW mice were exposed to 0, 55, 100, or 200 ppm TOC vapor. Exposures were conducted 6 hours/day, 5 consecutive days/week: for a total of 10 exposures. Parameters monitored included appearance and demeanor, body weights, hematology, clinical chemistry, organ weights, and gross patho logical and histopathologi 1 examinations. Signs of toxicity observed among mice on test Included rough hair coats, palpebral closure, and lethargy. The severity of chase signs of toxicity was exposure level dependant. Mortality, statistically significantly lower mean body weights, increased liver and kidney weights, and an increased activity of serum glutamic pyruvic transaminase also occurred among mice on test; again, these parameters were dependent upon the exposure level. Prom gross and histo pathologic examination, it was determined that mala mice of all exposure levels experienced a marked degree of nephrotoxicity, with renal failure accounting for mortality in the 20Q ppm exposure group. Renal toxicity was in significant In all female mica on test when compared to mala mica of the same strain. However, hepatotoxicity was more prevalent In female mica than in male mice of the same strain and exposure level. Overall, the data suggest that male mica were affected by exposure to VDC vapor to a greater degree than were female mice of the same strain and expoaura level. Based on pathology of surviving mice, male CD-I mice were the most severely affected at all levels of exposure with moderate to severe degenerative nephrosis seen at all exposure levels (55, 100, and 200 ppm). SL 068128 INTRODUCTION Recent studies have shown a discrepancy In response to Inhalation of vinylidene chloride (VDC) vapors among different strains of mice. Male and female mice were exposed to 55 ppm VDC 6 hours/day, 5 days/week for up to 9 months in a study conducted by Lae, at al (1978) Although develop ment of 3 hepatic hemangiosarcoma and 6 Instances of bronchioalveolar adenoma and/or acinar proliferation in the lung were reported in the 70 (35/sax) mice examined, the survival rate of these mice was good. The strain of mouse used in fchj-s test was CD-1 (Charles River Breeding Laboratories, Inc., Wilmington, MA). In a long-term (1-year exposure followed by observation until "natural" death) study conducted by Maltoni (1977 a,b), Swiss-Webster mica have bean exposed to 10, 25, or 50 ppm VDC. Maltoni reported 10 ppm to be a no-adverse effect level. However, tumors of the kidney along with other toxic changes in the kidney were reported at the 25 ppm exposure level, and, in contrast to mica in the Lee, et al (1978) study, the 50 ppm- level was near the lethal dose; 7 of 60 mice survived the exposure, 4 hours/day, for 1 week. Maltoni (1977a) has also conductad a comparison among 4 strains of mica. These animals were exposed for 2 consecutive days to 200 ppm VDC for 4 hours/day. After 9 observation days, the following survival rata was reported for each strain: Mouse Strain Balb/c Swiss-Webster CjH c37si6 Survival Rate Male 'Patna 1 a 6/30 9/60 13/30 23/30 30/30 60/60 19/30 30/30 The results of the test on the strains used by Maltoni (1977) wera rela tively comparable with regard to survival. However, a mouse comparable to the CD-I strain used by Lee, et al (1978) was not used in this study. SL 068129 The question of varying responses to VDC among different mouse strains therefore remains unanswered. The purpose of the following study was to Investigate the effects of exposure among strains used in oncogenic studies and the relative degree of such responses. In this subchronic inhalation study, 4 strains of mice were exposed to VDC vapor. Each strain, and the reason for its choice, is given below. Strain Ha(ICR) B6C3F1 CD-I CE-W Reason for Choice The strain of mouse used in the Dow Toxicology Research Laboratory in previous VDC vapor studies. The mouse strain used by the National Cancer Institute (NCI) and currently in use in the Dow Toxicology Research Laboratory. The strain of mouse used by Lee, at al, in the long-term VDC study (the animals used in the present study were obtained from the same supplier). A strain of Swiss-Webster derived mouse believed genetically comparable to chat used by Maiconi in his long-term VDC study. SL 06813 MATERIAL Production-grade VDC was obtained from the Michigan Division, Dow Chemical, USA. The material used in this study was analyzed for impurities using a Flanigan 31QQ-D quadrupole gas chromatograph/mass spectrometer (electron impact), with the following results:4' Component 1.1- dichloroethylane (VDC) chloroethylene 1.2- dichloroethylene 1,1- or 1,2-dichloroethane trichloroethylene Area Percent 99+2 <0.12 <0.12 <0.12 <0.12* *Analysed by E. A. Hermann, Dow Toxicology Research Laboratory, SL 068131 5- METHODS Chambers, Vapor Generation, and Analysis. Exposures were carried out in stainless steel and glass chambers of one cubic meter volume under dynamic airflow conditions. Air temperature humidity were monitored daily and controlled to levels acceptable for laboratory rodents. VDC vapor was generated by metering the liquid at a controlled rata with a precision syringe pump into a heated (45*C) vaporiz- ion flash. The vapor was chen diluted and swept with filtered air into the -ain chamber airflow at a rate calculated to provide 8-12 air changes/hour. The nominal concentration of VDC vapor In each chamber was the ratio of the rata at which liquid VDC was dispensed to Che rate of total chamber airflow. The concentration of VDC vapor in each chamber was monitored using a Miran I infrared spectrophoto meter with silver bromide windows and lens. The wavelength was 12.75 u, while the pathlength was 8.25 M. Each chamber was sampled for 15 minutes of a 60- minuta time cycle throughout each exposure day. Du Licate air standards of 55, 100, 150, and 200 ppm VDC were used to prepare a standard curve. An air standard of 100 ppm VDC was analyzed each exposure day to verify the standard curve. Values for chamber concentration were interpolated from the standard curve, time-weighted averages were calculated daily for each chamber. An-tmAla . ArHTrials used In this study were Ha(ICR) mice (Spartan Research Animals, Inc., Haslett, MI), B6C3F1 mica (Charles River Breeding Laboratories, Wilming ton, MA), CD-I mice (Charles River Breeding Laboratories, Wilmington, MA), and CE-W mice (Charles River Breeding Laboratories, Portage, MI). The. age SL 068132 * -6- and weight ranges of each 3ax and scraln of mouse upon arrival in this laboratory vara as follows: Age at Weight Bangs Age at Weight Range . Sex Strain Arrival at Arrival First Exposure First Exrosu: M Ha (ICS.) 26 days all 22 grams F Ha (Id) 26 days 24-26 grams M B6C3F1 31 days 16-20 grams F B6C3F1 29 days 14-16 grains M CD-I 27 days 18-20 grains F CD--1 32 days 18-20 grams M CF-W 31 days 16-20 grams F CF-W 31 days 14-18 grams 34 days 34 days 42 days 40 days 35 days 40 days 40 days 40 days 24-35 grams 16-28 grams 22-26 grams 18-23 grams 27-34 grams 17-27 grams 22-29 grams 21-26 grains Exposure. Four groups of mica, consisting of 10 mica/sex/strain/exposure level, were exposed to 0 (filtered room air), 55, 100, or 200 ppm VDC. All exposures were conducted 6 hours/day, 5 consecutive days/week for 10 days over a 12-day period. Mice of each strain were randomly assigned to treatment groups from single lots of q using the computer program G3AND. CL1ST (Computation Laboratory, Dow Chemical, U.S.A.). During exposure, mica vara placed in the chambers in exposure cages containing 10 animals of the same sex and strain. Following exposure, group of 10 mica was placed in plastic holding cages containing ground corn cob bedding. Food (Furlma Bat Chow pellets) and water were not available during exposure periods, but were available ad libitum at all other times. All mice were exposed to 12 hours of light and 12 hours of darkness each day. SL 068133 Body weights of all mica on Cast vara obtainad prior to exposure, and twice weekly during exposure. Mica ware observed daily for signs of tcxicity and changes in appearance and demeanor, as well as to remove dead or moribund animals. Organ Weights, Clinical Chemistries, and Pathology. An effort was made to terminate all moribund animals prior to actual death In order to avoid post-mortem autolysis. Blood was collected from 5 moribund mice of 3 strains from the 200 ppm level for clinical chemistry determinations. All other mice subjected to gross pathological examination prior to termination were either dead or so close to death that blood samples were not obtained. On the morning following the tenth day of exposure for each strain, all surviving mice of that strain were sacrificed. The mice were lightly anesthetized with methoxyflurane; blood samples for clinical chemistry deter minations were collected from the orbital sinus; and the mice were killed by decapitation. All mice, whether dead, killed in a moribund state, or killed at termini an of the study were given a gross pathologic axaau tion by a veterinary pathologist. Serum obtained from *1i surviving mice was used for determinations of blood urea nitrogen (BUN), and the activities of serum glutamic pyruvic transaminase (SGFT) and gamma glutamyl transpeptidasa (Y-GT).a The eyes of all mice were examined in situ immediately after decapita tion by of a glass microscope slide technique and fluorescent illumina tion. This technique was also applied to those mica presented in a moribund state. aCantrifiChem System, 400, Methods File, Union Carbide Corp., Rye, SY. SL 068134 Following decapitation, Che liver and kidneys of terminal kill mice were removed and weighed. Selected tissues showing gross pathologic changes in the mice which were submitted dead or moribund were saved in buffered 10% formalin. In all mice from the terminal kill the esophagus, trachea, lung, heart, mediastinal lymphoid tissue, liver and kidneys were saved in buffered 10% formalin. The lungs, trachea, esophagus, and mediastinal lymphoid tissue from 5 mice/sax/strain/exposure level were embedded as a unit in paraffin, prepared by routine histologic procedures, tissue slides stained with hematoxylin and eosin, and evaluated by light microscopy. In addition, the livers of 5 mice/ sex/strain/level from each mouse strain and a total .of 10 kidneys from each sex and exposure level of each mouse strain were similarly prepared and were evaluated by light microscopy. Statistical Evaluation. ClipicaT chemistry, body weight, and organ weight data, as well as organ to body weight ratios, were evaluated using an analysis of variance and Dunnett's test (Steel and Torrie, 1960), the level of significance for all cases being p <0.05. SL 068135 RESULTS VDC Vapor Concentration. Mean analytical concentrations to which each strain of mouse was exposed, and temperature and relative humidity recorded during exposures are presented in Table 1. From the mean analytical concentration for each chamber, it can be seen that all strains of mice vers exposed to basically the same concentration at each exposure level. ",aily te~. erature and humidity were also quite stable for each chamber. Animal Observation. Mortality of all strains of mice exposed to VDC vapor is given in Table 2. Regarding mortality, B6C3F1 mice of both sexes were the most sensitive of all strains tasted. Male mice of the CD-I and CF-V strains were affected to a greater degree than were female mice of the same strains. Table 3 gives the signs of toxicity observed in all mice on test. Many of the mice on test experienced lethargy, rough hair coats, and palpebral closure; these signs of toxicity occurred with the greatest frequency and severity among male female CF-W mice of the 100 and 200 ppm exposure groups. Male mice tended to be affected to a greater degree than female mice in the Ha(ICR), CD-I, and CF-W strains. Although B6C3F1 mica had the greatest mortality of the 200 ppm exposure group mice, the 55 and 100 ppm exposure groups of this strain exhibited no adverse affects in terms of signs of toxicity observed in the live animals. SL 068136 f -10- Bodv Weights. Mean body weights for all male mice are given in Figure 1, while chose for all female mice are given in Figure 2. The body weight and/or body weight gain of male Ha(ICR) mice was de pressed co some degree for ell exposure groups compared to Che control group. The weight suppression was apparent in an exposure-related fashion in that the higher exposure groups were affected the most. The mean body weight gains of female Ha(ICR) mice of ell exposure levels were comparable to chose of concrols throughout the study, with the following exception: final body weights of the 55 an4 200 ppm groups were statistically lower chan chose of the control group. Mean body weights of both male and female 36C3F1 mice in the exposure groups which survived were comparable to those of controls throughout the study. M>an body weight gains of the surviving group of male CD-I mica were lower rhan controls in an exposure-related manner. By the end of the study the male CD-I mice of the 55 ppm group were statistically comparable, although still lower chan controls. The mean body weight of female CD-I mica of the 200 ppm exposure group was significantly lower than the control at the first weighing. For the remainder of the study, however, the body weight for the 200 ppm group was comparable to the control group. Mean body weights of female CD-I mice exposed to 55 or 100 ppm VDC vapor were comparable to those of controls through out the study. Mean body weights of mala CF-W mica of the surviving exposure groups were comparable to those of the control group throughout the study. In female CF-W mice, imb body weight of the 200 ppm group was depressed at the first weighing. However, the weight for this group was comparable to tha control group for the remainder of the study. Mean body weights of female CF-W mice SL 068137 n -u- or the 55 and 100 ppm groups ware statistically significantly grsatar eh*n chose of controls in the early part of the study, but this was thought to be due to a weighing error rather than a treatment related effect. Organ Weights. Absolute and relative liver and kidney weights of all mica are given in Table 4. Statistically significantly increased relative liver weights (and increased absolute weights where the superscript "a'* appears) occurred among: Male Ha (ICS.) mice of Che 55,a 100, a and 200 ppm groups; female Ha (ICS.) mice of the 200 ppm group; male B6C3F1 mice of the 55 and 100a ppm groups; female B6C3F1 mice of the 55a 100a ppm groups; female CD-I mica of the 2Q0a ppm group; male CF-W mice of the 55 and 100a ppm groups; and female CF-W mica of the 55,a 100,a and 200a ppm groups. Although there are exceptions in specific groups, overall there appears to be an increase in liver weight relative to body weight that increases with increasing exposure level. Statistically significantly increased relative kidney weights (and absolute kidney weights where the superscipt "a" appears) occurred among male and female HadCB.) mice of the 200 ppm group; male and female B6C3F1 mice of the 100 ppm group; male CD-I mice of the 100 ppm group; and female CF-W mice of the 55 (absolute only), 100a, and 200a ppm groups. The increases in relative liver and kidney weights were considerad to be treatment-related and, in general, consistent with pathologic changes described in the Pathology section. Clinjgal Cheasitry. Mean clinical chemistry values of mice on test are given in Table 5. Although very significant kidney injury was seen upon pathologic examination SL 068138 f -12- of mala mice, a statistically significant increase in BUN occurred only among male B6C3F1 mice of the 100 ppm group. This indicates that measurement of BUN levels was not a useful criterion of kidney Injury in this case. Statistically signficant Increases in the activity of SGPT occurred among male Ha(ICR) mice of the 100 and 200 ppm groups, mala and female B6C3F1 mice of the 100 ppm group, female CD-I mice of the 200 ppm group, and female CF-W mice of the 100 and 200 ppm groups. Although not statistically significant (probably because of high variability), values for SGPT activity were clearly high among female Ha(ICR) mice of the 200 ppm group, male and female CD-I mice of the 100 ppm group, and male CF-W mice of the 100 ppm group. The finding of elevated SGPT levels is consistent with the gross and/or histopathologic findings of adverse effects on the liver as reported below. No pattern of change to indicate a treatment-related affect was seen in y-GT values. Pathology. The gross pathologic findings in the male mice of the various strains are presented in Table 6. Examination of the data in this table reveals that ail mice of all strains, except the Ha(ICR) strain, exposed to 200 ppm VDC were either dead or moribund when submitted for autopsy. No mice from the 100 or 55 ppm VDC groups showed evidence of a moribund state or died prior to the terminal kill. Treatment-related changes were grossly detectable in the kidneys of all strains of male mice at all dose levels. In addition, the liver showed a treatment-related change in all strains of mice from the 200 ppm group and in most strains from the two lower dose groups. The Ha(ICR) and B6C3F1 male mice appeared to show evidence of SL 068139 a decrease In the sire : the thymus. Changes present In the lung were con sistent with those seen as spontaneous in occurrence and were not directly effected by treatment. The grossly recognized changes in the gastrointestinal tract were secondary to the renal failure and probable anorexia associated with treatment. Histopathologic findings for the various strains of male mica are presented in Table 7 (Ha(ICS)), Table 8 (B6C3F1), Table 9 (CD-I), and Table 10 (CF-W), re spectively. Each table presents the exact histopathologic criteria in the various organs which were used for evaluation and comparison of the various strains of mice. Liver and kidneys were the principal target organs which showed histo pathologic changes considered treatment related.' These changes were present at ail exposure levels in all strains of male mica tested. The kidneys show a greater degree of toxicity Chan the liver at all exposure levels. Although renal toxicity was still quite severe In all strains at the 35 ppm level, it was most severe in the CD-I strain. To thoroughly compare the relative renal toxicity in the various strains of mice, it would be necessary to examine animals from lower exposure levels. Findings of lung changes associated with mica exposed to vapors of TOC were not confirmed in study. In an occasional control as well as created mouse there were changes characterized by acute congestion, focal acuta Interstitial pneumonitis, focal alveolar histiocytosis, or pneumonia. These were spontaneous in occurrence and did sot show a treatment--relatad effect in ari-fmatg which survived the exposure. Animals moribund or dying from renal failure may show a accentuation of these findings; however, those sur viving the exposure did not. Therefore these pulmonary effects are not a direct result of TOC toxicity in the lungs but secondary to the renal failure. 068l>0 SL r -14' The gross pathologic findings in the female mice of the various strains are presented In Table 11. Examination of the data In this table reveals that nearly all female mice of all strains at all dose levels survived the exposure period, except the 200 ppm Ha(lCS.) and B6C3F1 groups. In general, the livers of female mice of the 200 ppm group only shoved some treatment-related effects. Occasional mice of the 200 ppm group of Ha(IC3.), CF-W and 36C3F1 strains showed suggestive kidney changes. In addition, several B6C3F1 mica from the 100 ppm group showed suggestive kidney changes. The CD-I female mica did not show a grossly detectable kidney change at any level. The Ha(ICR) control and treated mice showed an Increased Incidence of lung changes which vara inter preted to be spontaneous. Many of the treated mica of this strain also showed a decrease in size of the thymus and a decreased amount of adipose tissue within the abdominal cavity. Histopathologic findings for the various strains of female mice are pre sented In Table 12 (Ha(IGO), Table 13 (B6C3F1), Table 14 (CD-I), and Table 15 (CF-W), respectively. Examination, of Che data in these tables indicates m-fn-tmai renal toxicity In an occasional 36C3F1 or CD-I mouse at the 200 ppm exposure level, only. Significant toxic renal changes were not detected In the kidneys examined from the Ha (ICH.) or CF-W mice at any level of exposure. In contrast to the marked renal toxicity of the mala mice, it appears that the liver In the female mice was Che more sensitive target organ. Pulmonary changes were not present which were considered treatment related In animals which survived the exposure. The cause of death In the Ha (ICS.) and B6C3F1 mice may be associated with the acute hepatotoxicity rather than nephro toxicity, although B6C3F1 mice did show some avldanca of both. SL 068141 DISCUSSION All of che strains of male mice used in this study experienced significant mortality, a finding consistent with Maltoni's (1977) mortality findings in 4 mouse strains exposed for 2 consecutive days to 200 ppm VDC for 4 hours. Maiconi also saw better survival in female mica than males, a finding consistent in general with the present study. It may also be signficant that all the female mice of the strain (Swisa-Webster) used by Maltoni for his long-term studies survived the short mortality experiment as did all the female CD-I mice in the present study. However, Maltoni's mice did not survive at 50 ppm VDC in his long-term study, but CD-I mice were reported to survive long-term exposure to 55 ppm VDC at Che Midwest Research Institute (Lee, et al., 1978). Pathologically, CD-I mice, especially males, were dramatically affected in this study. With the moderate to severe degenerative nephrosis seen in male CD-I mice (Table 9) after only 10 days of exposure to 55 ppm VDC, it seems unlikely that these mice could survive a long-term inhalation study. Certainly if they did survive, any effects seen would have to have been confounded by the presence of these early extensive kidney effects. The female CD-I mice did not exhibit degenerative nephrosis, but significant hepatocellular degeneration and necrosis along with centrilobular hepatocellular swelling and pleomorphism at the 200 and 100 ppm VDC levels after only 10 days of exposure suggests that longer exposure at the lower level could lead to liver toxicity. Although it is not passible to carefully rank the 4 strains of mica as Co sensitivity, the results of this study lead to several general conclusions. SL 068142 r *16-- 1. A few repeated Inhalation exposures of mice to 200 ppm VDC, as evidenced by the 4 strains of mice In the present study and the 4 strains of mice In the Maltoni (1977a) mortality study, produced significant mortality. 2. Hale mice were more sensitive to VDC than female mice, as evidenced in 7 of the 8 strains of mice tested in either the present study or in the Maltoni (1977a) study. 3. Significant pathological change was seen in the kidney (and liver) of the male CD-I mice (the strain used by Lee, at el (1978)) at levels as low as 55 ppm VDC. Written By: Reviewed By: SL 068143 1 r* -17 REFERENCES Lee, C. C-, J. C. Bhandari, J. M. Winscon, and W. B. House (1978). Carcinogenicity of Vinyl Chloride and Vinylidene Chloride. Journal of Toxicology and Environmental Health, 4:15-30. Maltoni, C. (1977a). Recent findings on Che Carcinogenicity of Chlorinated Olefins. Environmental Health Perspectives, 21:1-5. Maltoni, C., G. Cotti, L. Mbrisi, and P. Chiaco (1977b). Carcinogen!-ity Bioassays of Vinylidene Chloride. La Medicine del Lavoro, 68:2^ 62. Steel, R.G.D. and Torrie, H. H. (1960). Principles and Procedures of Statistics. McGraw-Hill Booh Company, Inc-, New York. SL 06814* a a (ff*f tHpMSiite ajTM latte I Ciaaier CMrMlfiilMi, irf *!*! ................ . & fffl .- - -Mm___ H.uiat m,,. . tM...... *......C-HtBl___ IWm___ SBttJH_ -WHI IU li li li 1* li li Anm.... . _Jl--------!!l-------&(!"!------ -------------- J**l ------ li it la i la la 1*0 t.i. M 4tM H4iu M.ui.i n.iii.i M.in.i i.ail.t m.hh.i ti.in.ir Ji.ui.t la.m.i vo.m.s li.tti.* ri.m.i ii.ih.i loiti.i M.iJi.i |f NitaUlly 41) t.i. U.H4.4 IVIi.) M.llU U.lll.l .SlM tl.llIJ U.liM It.*0.1 W.llfc.l H.Jli.t W.llU 11*10-1 M.ill.) Sl.lli.J Ml|ti<i'J Aalp4t(*l Vutt,| rJlIoit U-ymt I S U w.tni.i n.iiii.i n.itii.i tMiia.i n.iii.t fi-mi.i 11*0.4 u.m.t itr.aoo.i w*.* iti.it*.* iti.n*.t <1 Hm UvIfllilcJ ftAtlfill ll .. I-Ht 4l llMI* wl lifMiauH' Hijf* MUM'* . u4 Ih-ait Au.ilyll*l 44.4M* u.tti.i 4t.*-M.i U.MI.I w.i-iot.i tw, 1 - lit .* at.4-tit. at.4-i*).i lat.i-nit.t 1*4.4-m*.* irt.r-Mt.t m.Mift I* ii i li >t al hia'AuK M|* Ullklli 1 ot Hi m Ati <lft it ill C*i***: t* v im viiIh*-* -* 4IIIc*kI fo ji* li NrMM tie etrelea mh eterlei m twcnllai 4*f H that eelf Mirjlti baiMltl Mat- It* k |m i 4i| el Mi* el eepoewte. SL 068145 19- v Table 2 Mortality of Mice Exposed to VDC Vapor* Exposure Level Strain 200 PPM 200 PPM Ha (ICS.) Ha(IC3.) Sex Male Female Total # Dead/ Total of Animals For Duration of Study 6/10 4/10 9 of Exposures To Reach Maximum Mortality 4 3 200 PPM 200 PPM B6C3F1 B6C3F1 Male Female 10/10 10/10 3 1 200 PPM CD-I Male 10/10 5 200 PPM 200 PPM CP-V CF-W Male Female 10/10 1/10 5 3 55 PPM Ha(ICS) Female 1/10 3 0 PPM Ha(ICS) Female 1/10 9 *No mortality was seen in strains or at levels not Included In the Table. Sh 0681*6 Table J Signs of Toxicity Exhibited ly Mice Exposed to VUC Vu|>ar St talu Sex lla(ICH) IMICR) lla(ICK) Ha(lCg) llafllttl M.ile Haiti Hale Female Female Female U6C1FI U6CIPI gbCJPl Hale Hale Hale BbClFI Bfil'.IPI HfcClFl KuMai 1 e Fewa 1 e Female CB-I Hale t:-l Hale ail Hale ai-i FtiHhl 1 ai-i Featii 1 e ai-i Female cf-m UF-W CF-tl CF-W CF-W tJF-M Male Hale Hale Female Kewi 1 e IVlHtl 1 *s Eapsaurt f.evel __________________________ Signs of Toalclty_____________________________________________________________ ____ _________ 55 PPM 100 ri-H 200 FPH 55 PPH 100 PPM 200 rPH ill had alightly rough hair coate. All had allghtly rough lialr coate, 20Z had aye Irritation cliarncturlrod by palpebral closure. All ware lethargic, Initially all had Moderately rough hair coate, 20-502 had palpebral closure. All had allghtly rough hair coats. All had allghtly rough hair coata. All wars lethargic Initially, all had Moderately rough hair coats, 20-JOI had palpebral closure. 55 PFH 100 PPH 200 PPH 55 *ph 100 PPH 200 PPH Ho adverse affects. Ho adverae affacta. All wars lethargic, all had very rough hair coata, 100X had palpebral closure, all were dead following the third uapoauro. Ho adverae affacta. Ho adverse affacta. All wore dead soon after the first exposure. 55 PPH 100 PPH 200 FFH 55 PPM 100 PPH 200 PPH All hed slightly rough hair coata. All hed allghtly rough lialr coate; halfway through tire study 201 lied palpebral closure. All were lethargic, all had uodaratsly rough lurtr coata, M-iOOl hud palpabral closure. All had slightly rough hair coata. All Irad allghtly rough lialr coata, 102 had palpabral cluaura. All wars lethargic, all had Moderate!y rough hair coate, 20-401 had palpebral closura. 55 PPH 100 PPH 200 PPH 55 PPH too PPH 200 PPH Halfway through the study, all bad slightly rough hair coata. All liad Moderately rough hair coata, 20-502 Irad palpabral closure. All were lethargic, all had very rough hair coata, 1002 had palpabral cloaura. 1/4-wuy through the study, all had allghtly rough hair coata. Halfway through tire study, all had slightly rough haircoata, 10-202 had palpabral closure. All were lethargic, all had vary rough lialr coats, 50-1002 had palpebral closura. SL 068l^7 Figure 1 Mean Body Weight (Grams) MEAN BODY WEIGHT OF MALE MICE EXPOSED TO VDC VAPOR Mean Body Weight (Grams) i iiIIIIi 10 0 2 4 6 8 10 12 14 16 0 Experiment Days ii t i* 2 4 6 8 10 12 14 16 Experiment Oays a) Statistically significant by analysis of variance and Qunnett's test, p <0.05. bl Mean body weights wiil no longer be shown due to excessive mortality. SL 068148 0 -22- Figure 2 Mean Body Weight (Grams) MEAN 300V WEIGHT OF FEMALE MICE EXPOSED TO VDC VAPOR Mean Body Weight (Grams) BgCj F, Strain - Exposure Days 02 5 8 10 --I--|--1--r--L"i--r-H--1 0 2 4 6 8 10 12 14 16 Experiment Days a) Statistically significant by analysis of varianca and Qunnen s test, p <Q.Q5. bl Mean body weighs will no longer ba shown due to excessive mortality. SL 068149 Tac.a 4 yaaa (s Standard 3aviacion) Tasainal iody Oaisbta. Orjan Vaisnca and Qrjan ea 3ody Waishe Racdoa of yisa Sxpeaad ca VDC Vapor Scxaix 3a CCS) 3a Ca) 3a Ca) 3a(:a) 3a(Id) 3a(Id) 3a (IS) 3a Ca) S6C3F1 36C2F1 36C3T1 86C3F1 36an 36C3FL a-L cd-i 00*1 CD^l <3^1 CD^L C3-1 aw C2W CIW CSW W CFW aw S-r. yaia Mala Hal* Xala Fmala Fala Fanala Fault HaLa Xa-la yala faaala Faoala Fanala Hal* Uala Sala Fanala Fnnala Fanala Fanala Hala Kala Mala Fanala Fanala Fanala Fala Sxpoaura Laval 0 F7K 53 ??!! LOO PPM :oo f?s 0 FW 33 m 100 PPM 200 rra 0 PPM 53 FPU LOO ?FM 0 PPM 55 PPM 100 PPM 0 PPM 35 m 100 7331 a ppm 35 PPM LOO PPM 200 PPM 0 PPM 53 PPM 100 PPM 0 PPH 33 PPM 100 PPM 200 FPU Fixal Sodv Vaiihc 36s3 33-2 34x2 2S=2 26=2 22*3* 22=3, 222* 26x2 26=1 26=1 22=1 22=1 22=1 34=2 31=2 27x5* 24x4 24=2 25x2 24x1 29x2 28x2 28X1 25X1 26X2 26x1 25x1 Orraa 'Jaizhea L.ivax Sidnav .* i/ICO 1 l 1/100 3 2.12x0.24 2.46x0.20* 2.47=0.29* 1.33=0.13 3.39x0.38 7.08x0.41* 7.32X0.37* 7.03x0.23* 0.-9=0.06 0.53=0.03 0.51=0.05 0.43=0.09 1.37=0.15 1.53=0.13 1.31=0.13 1.74=0.46* 1.40x0.23 1.20X0.18 1.29X0.16 1.24=0.14 3.38x0.69 3.48x0.31 5.55x0.40 6. yj.40* 0.27=0.04 0.23=0.03* 0.24=0.03 0.26=0.03 1.06x0.10 1.08x0.10 1.04-C.33 1.20=-. 3 1.44x0.16 1.37x0.12 1.70x0.08* 5. J-34 5.. 0.32 6.5--0.23 0.36=0.04 0.36x0.03 0.38x0.02 L.36*. . .1 1.36=0.37 1.45=0.06 1.11=0.08 1.22=0.12 1.34x0.10* 3.02=0.27 3.44=0.35* 6.02=0.43 0.25x0.02 0.26x0.02 0.28x0.02 1.14x0.10 1.16=0.06 1.25=0.10* 1.96x0.21 1.99X0.31 1.73x0.30 5.79=0.36 6.32x0.62 6.27X0.72 0.45x0.03 0.43x0.04 0.47x0.05 1.34=0.12 1.42x0.10 1.40=0.64* 1.16x0.27 1.15x0.15 1.25x0.15 1.43=0.12* 4.37=0.89 4.71=0.41 3.02=0.43 3.87x0.25* 0.28x0.05 0.26x0.03 0.31=0.04 0.29x0.04 1.19x0.23 1.06x0.10 1.23=0.14 1.18=0.13 1.63X0.14 1.77x0.15 1.84x0.18* 3.74x0.31 6.23x0.43* 6.65x0.30* 0.43X0.05 0.39x0.04 0.43=0.06 1.49=0.17 1.39=0.14 1.56x0.16 1.19x0.10 1.28x0.11 1.34x0.11* 1.77x0.19* 4.83x0.30 3.36x0.31* 6.03x0.33 6.97=0.33* 0.28X0.02 0.31=0.02* 0.31=0.03 0.33=0.02 1.13x0.08 1.19=0.06 1.22x0.09* 1.32x0.06 4 Scaclaclnally t*niicaae by analyaia f rarlanca and Dusnacs'a eaac, p <0.03. SL 068150 Strain Ha(ICR) Ha(ICR) B6C3F1 B6C3F1 CD-1 CD-1 CTW CFSW Table 5 Mean ( S.D.) Terminal Clinical Chamiscry Valuas for Mice Exposed to VDC Vapor Sex Mala Female Male Female Male Female Male Female Exposure Level 0 PPM 55 PPM 100 PPM 200 PPM 0 PPM 55 PPM 100 PPM 200 PPM 0 PPM 55 PPM 100 PPM 0 PPM 55 PPM 100 PPM 0 PPM 55 PPM 100 PPM 0 PPM 55 PPM 100 PPM 200 PPM 0 PPM 55 PPM 100 PPM 0 PPM 55 PPM 100 PPM 200 PPM BON _N (me/100 oil 10 27l7 10 29x5 10 31i9 4 38X20 9 25i4 S 265 10 29x6 5 24x4 10 28i4 10 27X5 10 34x4 10 26X5 10 24x5 10 21x3 10 25X3 10 32i9 9 62X105 10 24X5 10 21x2 10 18X3 * 10 13x4a 10 38X30 10 30X5 10 32X5 10 26X4 10 25X6 10 23X3 9 26x2 SGPT (mu/al) 22x3 24x5 37115 54x18* 27H5 3016 4013 213x133 27 no 2517 50130 13x5 25no 31112* 1717 37124 71195 1815 26116 29X15 39X13 42131 3214 52111 32X15 28H6 75l30a 111x36 Y-GT (mu/n) 2n in 111 m 2l4 3x1 2X3 2x1 2il 2x1 312 313 1*0 2*0 4l2 3l2 2*2 2*1 3X2 2*0 3x1 m 3*4 lxl 314 2x1 m m a Statistically significant by analysis variance and Dunnecc's test, p <0.05 SL 068151 -ii unx (BOSS 9ATH0LCCIC OBSSVATIOSS FOR crosa to tctjes "3AL STSAErs or &.IS. :GCI -rue vapors \ > - .'toua Strain Oaaacal Livr illdaaT Luna Can croiatu tmai v* Tract 4 !i 5i HnCCR) Cancrnl 33 ?P* LOO ppm 2oo ppn ?! > t9o 9 -1 9 to 3t1o* --13 *$ LO/LO 0/L0 1/L0 0/L0 3 to i 3 U t4o to 3 n 9/XO 0/LO 0/L0 S/LO 1 tt3o3o 1. 99 9> I9f 39 U 99 a t3o >9 3 t9o t9o to <* h il 0/10 0/10 0/10 0/10 10/10 10/10 10/10 4/a aacon Control 33 n> LOO ppn 200 ppa L0/L0 2/L0 0/L0 0/L0 0/10 0/10 0/10 9/10 0/10 0/10 0/10 1/10 10/10 3/10 a/a 0/10 CD-I Cancm! 33 W , Loo ppm 200 ppm 9/10 0/L0 0/9 0/L0 0/L0 0/10 0/9 7/10 0/10 0/10 0/9 3/10 a/a a/io 9/9 o/a aw Canera 1 33 ?p* LOO ppn 200 ppm L0/L0 2/L0 0/L0 0/L0 0/10 0/10 0/10 S/LO 0/10 0/10 0/10 2/10 a/a a/a 10/10 o/a 3 a =i inn *x 9y4a y 3 ^W99N* 9to* --3 9& to 3 y 3 to <49tV5o --9a3 mt59^o 4a3a9-3t9yo to --a3 5 si 0/10 2/10 3/10 s/a o/a 1/10 1/10 8/10 0/10 i/a 3/9 6/a a/a 0/10 o/a a/a 3 4 tta>aa439oao9 9m939 3 0/10 io/a 9/a a/a 0/10 8/10 a/a 9/a 0/10 a/a 9/9 9/a 0/10 a/io 10/10 10/10 a y 3 a 3 3 ttoo ] to a I o/a 0/10 o/a i/a o/a o/a o/a o/a o/a o/a 1/9 i/a o/a o/a o/a o/a Suabc \t:*i*d/otmb*c abanrvnd. *0m bu* gncapnd daring uponon and wnn aoe arai-Ubia for aucopnf. aa 3 i 3 j 1tao 3 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 1/10 0/10 1/9 0/10 0/10 0/10 0/10 0/10 y 9 tao to Jtfot 9aa9 to ^a t3ao t33ov 3 j 3y 3y3 s tayo si tao ato 9 e-- --T-2______ '0/10 0/10 0/10 o/a 0/10 0/10 0/10 o/a N a ta99yo j 0/10 3/10 3/10 2/a 0/10 o/a o/a o/a o/a 0/10 0/10 0/10 o/a 1/10 1/10 o/a 0/10 0/10 0/9 4/10 0/10 0/10 0/9 2/10 0/10 0/10 0/9 0/10 0/10 0/10 0/10 1/10 0/10 0/10 0/10 1/10 0/10 0/10 0/10 0/10 SL 068152 TABLE 7 HISTOPATHOLOGIC OBSERVATIONS FOR Ha (ICR) MALE MICE EXPOSED TO VimiDENE CHLORIDE VAPORS Microscopic Observation Exposure Concentration 0 pom 55 ppm 100 pom 200 ?pn Liver (5) (5) (5) (5) Focal mononuclear cell aggregates, minimal 5 240 Normal-appearing glycogen deposited within hepatocyte cytoplasm 5 1 10 Centrilobular hepatocellular swelling 0 3 5 2 Accentuated lobular pattern 00 04 Focal or diffuse hepatocellular necrosis, minimal 0000 moderate 0003 severe 0000 No change considered treatment related 5 200 Kidneys (5) (5) (5) (5) No change considered treatment related Focal mononuclear cells 5 00 0 1 00 0 Focus of tubular degeneration and atrophy - spontaneous 1 00 0 Degenerative nephrosis - treatment related, minimal moderate severe 0 2 10 0 34 1 0 00 4 Mediastinal Lymph Node No change considered treatment related Atrophy Necrosis (5) (2) (3) (0) 5230 0 0 00 0 000 Thymus No change considered treatment related Atrophy Necrosis (5) (5) (4) (1) 5540 000 1 000 1 ( ) Number in parentheses indicates number of tissues examined. Data listed as number affected. i -27 TABLE 7 (Continued) HISTOPATHOLOGIC OBSERVATIONS FOR Ha(ICR) MALE MICE EXPOSED TO VINYLIDENE CHLORIDE VAPORS Microscopic Observation Trachea No change considered treatment related Lungs Focal acute pneumonia No change considered treatment related Acutely congested Acute interstitial pneumonitis Focal alveolar histiocytosis Esophagus No change considered treatment related cioosure Concentration 0 ppm 53 ppm 100 pom 200 atm (5) (5) (5) (3) <3) (5) (5) (5) 2112 5550 0002 1005 2130 (5) (5) (4) (4) ( ) Number in parentheses indicates number of tissues examined. Data listed as number affected. SL 068154 4 iV -28- TABLE 8 HISTOPATHOLOGIC OBSERVATIONS FOR 36C3F1 MALE MICE EXPOSED TO VINYLEDENE CHLORIDE VAPORS Microsconic Observation Exposure Concentration Q p-QTa 53 com 1QQ nom 200 com Liver (5) (5) (5) (5) Focal mononuclear cell aggregates, miaiTTtal 5 450 Normal-appearing glycogen deposited within hepatocyte cytoplasm 5420 Centrilobular hepatocellularswelling 0 130 Accentuated lobular pattern 0000 Focal or diffuse hepatocellular necrosis, minimal 0 100 moderate 0000 severe 0005 No change considered treatment related 5 4 20 Kidneys (5) (5) (3) (5) No change considered treatment related S000 Focal mononuclear cells 1000 Focus of tubular degeneration and atrophy - spontaneous 0000 Degenerative nephrosis - treatment related, minimal 0100 moderate 0240 severe 0215 Mediastinal Lymph Node No change considered treatment related Atrophy Necrosis (5) (0) (4) (4) 50 42 00 0 0 00 0 2 Thvmus No change considered treatment related Atrophy Necrosis (3) (5) (4) (0) 55 00 00 40 00 00 C ) Number in parentheses indicates number of tissues examined. Data listed as number affected. SL 068155 29- ^ 4 +- TABLE 8 (Continued) HIST0P-,'H0L0GIC OBSERVATIONS FOR B6C3F1 MALE MICE ECPOSED TO VINYLIDENE CHLORIDE VAPORS Microscopic Observation Trachea No change considered treatment related Lungs Focal acute pneumonia No change considered treatment related Acutely congested Acute Interstitial pneumonitis Focal alveola; histiocytosis Esophagus No change considered treatment related Exposure Concentration 0 oom 55 oom 100 ppm 200 oom (4) (4) C3) (1) 44 31 (5) (5) (5) (5) 0 0-1 0 5551 0000 0004 00 10 (5) (4) (4) (3) 54 4 3 ( ) Number in parentheses indicates number or tissues examined. Data listed as number affected. SL 068156 i -30- TABLE 9 HISTOPATHOLOGIC OBSERVATIONS FOR CD-I MALE MICE EXPOSED TO VINYLIDENE CHLORIDE VAPORS Microscopic Observation Exposure Concentration 0 doth 55 ppm 100 oom 200 aom Liver (5) (5) (5) (5) Focal mononuclear cell aggregates, minimal 5530 Normal-appearing glycogen deposited within hepatocyte cytoplasm 5 2 10 Centrilobular hepatocellular swelling 0 3 2 0 Accentuated lobular pattern 0030 Focal or diffuse hepatocellular necrosis, minimal 00 10 moderate 0000 severe 0015 No change considered treatment related 5 200 Kidneys No change considered treatment related Focal mononuclear cells Focus of tubular degeneration and atrophy - spontaneous Degenerative nephrosis - treatment related, minimal moderate severe (5) 5 0 1 0 0 0 (5) 0 0 0 0 0 5 Mediastinal Lymph Node No change considered treatment related Atrophy Necrosis (5) (5) (5) <2) 5550 0001 0002 Thymus No change considered treatment related Atrophy Necrosis (5) (3) (5) CO) . 53 50 00 0 0 00 00 ( ) Number in parentheses indicates number of tissues examined. Data listed as number affected. SL 068157 -31- 4 4- TABLE 9 (Continued) HISTOPATHOLOGIC OBSERVATIONS FOR ID-1 MALE MICE EXPOSED TO VUTCLIDENE CHLORIDE VAPORS Microscopic Observation Trachea No change considered treatment related Lung;' Foca_ .cute pneumonia No cc .ge considered treatment related Acutely congested Acute interstitial pneumonitis Focal alveolar histiocytosis Esophagus No change considered treatment related Exposure Concentration 0 ppm 55 ppm 100 pom 200 tom (3) (1) (0) (3) 3 103 (5) (5) 00 3) (5) 10 5550 0004 00 0 3 0000 (4) (5) (4) (3) 45 43 ( ) Number in parentheses indicates number of tissues examined. Data listed as number affected. SL 068158 TABLE 10 HISTOPATHOLOGIC OBSERVATIONS FOR CTO MALE MICE EXPOSED TO VtNTLIDENE CHLORIDE VAPORS Microscopic Observation Exposure Concentration 0 oom 55 oom 100 ppm 200 ppm Liver Focal mononuclear cell aggregates, minimal Normal-appearing glycogen deposited within hepatocyte cytoplasm Cantxilobular hepatocellular swelling Accentuated lobular pattern Focal or diffuse hepatocellular necrosis, moderate severe No change considered treatment related (5) 3 5 0 0 0 0 0 5 (5) 0 0 0 0 0 0 5 6 Kidneys No change considered treatment related Focal mononuclear cells Focus of tubular degeneration and atrophy - spontaneous Degenerative nephrosis - treatment related, minimal moderate severe (5) 5 2 0 0 0 0 (5) 0 0 0 0 0 5 Mediastinal Lvmoh Node No change considered treatment related Atrophy Necrosis <4) (5) (5) 45 5 ooo 00 0 (4) 0 1 4 Thymus No change considered treatment related Atrophy Necrosis (5) (5) (3) (0) 5530 0000 0000 ( ) Number in parentheses indicates number of tissues examined Data listed as number affected. SL 068159 --33- + 4 TABLZ 10 (Continued) HISTOPATHOLOGIC OBSERVATIONS FOR CTff MALE MICE EXPOSED TO VINYLIDENE CHLORIDE VAPORS Microscopic Observation Trachea No change considered treatment related Lungs Focal acuta pneumonia No change considered treatment related Acutely congested Acuta Interstitial pneumonitis Focal alveolar histiocytosis Esophagus No change considered treatment related Exposure Concentration 0 oom 55 pom 100 ppm 200 oom (3) (0) (2) (3) 30 23 (5) (5) 00 (5) (5) 00 5550 0005 0000 0000 (1) (1) (4) (3) 114 3 ( ) Number in parentheses indicates number of tissues examined. Data listed as number affected. 0&8^ * t> ;I4 f-ia XtfU LI G30SS PATHOLOGIC OHSISlVAtlOMS FOR SEVI3AL 3TSAIKS OF HMALS HICS CT0SE3 TO VOTUDE3E CHLORIDE VAPORS Central Ll'rr Kldaity Lao* Msu* de7**d In ii vied d*- eTM*i ai?o* Cancraincutdnal eljiu* in jo- Sv Trace gyvgua dceir.al cavder ** 2 C 2? X -* s1 a 11 -3 *21 M3 y9 23 -*9 *3-- 1 a I *3 39 a 0 y' 11 5 *33 1* s i y 3 4 > 3X9 -a ays 9g ay ya 'a a Xa t3y >3 <3y 93 y i* y *6 9* 1_JJL 1 |a ^ x3 Taucral 53 ppa 100 7pa 200 ppn a/io 3/10 4/10 0/10 1/10 1/10 0/10 4/10 0/10 0/10 0/10 1/10 9/10 1/10 0/10 Q/10 5c:n Zouesol 55 ?pn 100 ppa 200 ?pa 10/10 10/10 3/10 0/10 0/10 0/10 0/10 10/10 0/10 0/10 0/10 0/10 10/10 10/10 2/10 0/10 O-l Canesnl 55 ?po 100 ppn ZOO ppa 9/10 10/10 10/10 5/10 TV Canenol 55 ppm 10O ppm ZOO ppm 10/10 10/10 10/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 1/10 0/10 0/10 0/10 0/10 10/10 10/10 10/10 10/10 0/10 0/10 0/10 0/10 10/10 10/10 10/10 9/10 ;uabr *ffM*d/tt*b*t aftnnrry. aay9 a<ya9w a9^x y3a3 9 m3y dS ^a m yyaayya Au a9 aU --xaa* y3 9ayaaa9 --9a& yy3y3ya-a^ y4* S'i g 52 0/10 0/10 0/10 7/10 0/10 0/10 1/10 9/10 0/10 0/10 0/10 4/10 0/10 0/10 0/10 10/10 W*4 a9y ! 9 9 ya9* aa3t a9*3 3 0/10 0/10 0/10 3/10 0/10 0/10 3/10 3/10 0/10 0/10 0/10 0/10 0/10 O/10 0/10 2/10 yaa aU ay a 9 s y i a A a 1 2/10 2/10 1/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 m 3 yg* I 0/10 0/10 o/ia o/io o/io o/io 0/10 0/10 1/10 0/10 0/10 1/10 0/10 0/10 0/10 a/io A V m3 3 9 yy I =3 =a -ue s-- o/io o/io 0/10 2/10 0/10 0/10 0/10 1/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 1/10 0/10 0/10 0/10 1/10 Ma 9 0/10 6/10 6/10 5/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 5/10 5/10 5/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/20 0/10 0/10 SL 068161 -35- ^4 V TABLE 12 HISTOPATHOLOGIC OBSERVATIONS FOR Ha(ICR) FEMALE MICE EXPOSED TO VINYLIDENE CHLORIDE VAPORS Microscopic Observation Exposure Concentration 0 pom 53 ppm 100 pom 200 pom Liver (5) C5) (5) (5) No change considered treatment related 55 40 Focal mononuclear cell aggregates, minimal 55 50 Normal-appearing glycogen deposited within hepatocyta cytoplasm 2000 Decreased amount of glycogen within hepatocyta cytoplasm 00 00 Accentuated lobular pattern, minimal . 0 0 0 4 marked 0 0 0 0 Centrilobular hepatocellular swelling and pleomorphism 00 15 Hepatocellular degeneration/necrosis 0 0 0 2 Acute congestion without necrosis 0 0 0 1 Kidneys (5) (5) (5) (5) No change considered treatment related 3555 Focal mononuclear cells 0000 Focus of tubular degeneration and atrophy -spontaneous 0000 Degenerative nephrosis - treatment related 0000 Mediastinal Lymph Node No change considered treatment related Reactive hyperplasia (0) ' Cl) (4) (2) 0 13 2 00 10 Thymus No change considered treatment related (5) (5) (4) (2) 55 42 ( ) Number in parentheses indicates number of tissues examined. Data listed as number affected. SL 068162 TABLE 13 HISTOPATHOLOGIC OBSERVATIONS FOR B6C3F1 FEMALE MICE EXPOSED TO VTNYLIDENE CHLORIDE VAPORS Microscopic Observation _______ Exposure Concentration 0 ppm 53 ppm 100 ppm 200 oom Liver (5) (5) (5) (5) No change conside treatment relaced Focal mononuclear -11 aggregates, minimal Normal-appearing glycogen deposited within hepacocyca cytoplasm Decreased amount of glycogen within hepatocyta cytoplasm Accentuated lobular pattern, aKnimai marked Cencrilobular hepatocellular swelling and pleomorphism Hepatocellular degeneration/necrosis Acute congestion without necrosis 5 5 5 0 0 0 0 0 0 5 5 5 0 0 0 0 0 0 20 50 30 20 10 00 30 10 05 Kidneys (5) (3) (5) (5) No change considered treatment related 5 5 50 Focal mononuclear cells 0 0 00 Focus of tubular degeneration and atrophy -spontaneous 1000 Degenerative nephrosis - treatment related 0005 Mediastinal Lymph Node No change considered treatment related Reactive hyperplasia (5) (0) (4) (0) 50 00 4 0 0 0 Thymus No change considered treatment related (5) (5) (5) (0) 5 5 50 ( ) Number in parentheses indicates number of tissues examined. Data listed as number affected. SL 068164 TABLE 13 CContinued) HISTOPATHOLOGIC OBSERVATIONS FOR B6C3F1 FEMALE MICE EXPOSED TO VIMYLIDENE CHLORIDE VAPORS Microscopic Observation Trachea No change considered treatment related Acute tracheitis Lungs No change considered treatment related Focal acute pneumonia Acutely congested Acute interstitial pneumonitis Focal alveolar histiocytosis Inflammatory cells within bronchi Esophagus No change considered treatment related Exposure Concentration 0 ppm 55 ppm 100 ppm 200 oom (5) (4) (2) (2) 5 420 0002 (5) (5) <5) (4) 5550 100 1 0000 0003 0020 0004 (5) (4) (5) (3) 3 ( ) Number in parentheses indicates number of tissues examined. Data listed as number affected. SL 068165 -39- * .** f" TABLE 14 HISTOPATHOLOGIC OBSERVATIONS FOR CD-I FEMALE MICE EXPOSED TO VINYLIDENE CHLORIDE VAPORS Microscopic Observation Exposure Concentration 0 pom 55 pom 100 ppm 200 opts Liver (5) (5) (5) (5) No change considered treatment relaced 5 5 00 Focal mononuclear cell aggregates, minimal 3 550 Normal-appearing glycogen deposited within hepacocyte cytoplasm 3 200 Decreased amount of glycogen within hepacocyte cytoplasm 1 000 Accentuated lobular pattern, minimal 0 0 5 4 marked 0 0 0 0 Centrilobular hepatocellular swelling and pleomorphism 0 054 Hepatocellular degeneration/necrosis 0 0 2 5 Acute congestion without necrosis 0 0 0 0 Kldnevs (5) (5) (5) (5) No change considered treatment related Focal mononuclear cells 55 53 2 0 00 Focus of tubular degeneration and atrophy -spontaneous 1 0 10 Degenerative nephrosis - treatment related 0 0 02 Mediastinal Lymph Node No change considered treatment related Reactive hyperplasia (5) (4) (5) (5) 5555 0000 Thymus No change considered treatment related (4) (3) (5) (3) 43 53 ( ) Number in parentheses indicates number af tissues examined Data listed as number affected. SV 4 by -40- TABLE 14 (Continued) HISTOPATHOLOGIC OBSERVATIONS FOR CD-I FEMALE MICE EXPOSED TO VINYLIDENE CHLORIDE VAPORS Microscopic Observation Trachea No change considered treatment related Acute tracheitis Lungs No change considered treatment related Focal acute pneumonia Acutely congested Acute interstitial pneumonitis Focal alveolar histiocytosis Inflammatory cells within bronchi Esophagus No change considered treatment related Exposure Concentration 0 non 35 soa 100 ppm 200 oom (4) (4) (3) (5) 4 435 0 000 (5) (5) (5) (5) 5 55 5 0 01 0 0 00 0 0 000 0 000 0 00 0 (4) (5) (5) (4) 455 4 ( ) Number in parentheses indicates number of tissues examined. Data listed as number affected. SL 068167 --41- *.4 ^ TABLE 15 HISTOPATHOLOGIC OBSERVATIONS FOR CFW FEMALE MICE EXPOSED TO VINYLIDENE CHLORIDE VAPORS Microscopic Observation Erasure Concentration Oppa 55 ppm 100 ppm 200 ppm Liver (5) (5) (5) (5) No change considered treatment related 5 100 Focal mononuclear cell aggregates, minimal 5 4 20 Normal-appearing glycogen deposited within hepatocyte cytoplasm 5 100 Decreased amount of glycogen within hepatocyte cytoplasm 0000 Accentuated lobular pattern, minimal 0 3 0 0 marked 0 0 5 5 Centrllobular hepatocellular swelling and pIsomorphism 0455 Hepatocellular degeneration/necrosis 0 0 2 5 Acute congestion without necrosis 0 Q 0 0 Kidnevs (5) (3) (5) (5) No change considered treatment related Focal mononuclear cells Focus of tubular degeneration and atrophy -spontaneous Degenerative nephrosis - treatment related 5 3 0 0 55 11 20 00 5 0 0 0 Mediastinal Lymph Node No change considered treatment related Reactive hyperplasia Thymus No change considered treatment related (5) (5) (5) (3) 5553 00 0 0 (5) (4) (5) (1) 54 5 1 ( ) Number in parentheses indicates number of tissues examined Data listed as number affected. 06168 SL 4 > -42- TABLZ 15 (Continued) HISTOPATHOLOGIC OBSERVATIONS FOR CFW FEMALE MICE EXPOSED TO VINYLIDENE CHLORIDE VAPORS Microscooic Observation Trachea No change considered treatment related Acute tracheitis Lungs No change considered treatment related Focal acute pneumonia Acutely congested Acute interstitial pneumonitis Focal alveolar histiocytosis Inflammatory cells within bronchi Esophagus No change considered treatment related Exdosura Concentration Q pop 55 onm 100 ppm 200 oom (2) (4) (4) (4) 24 4 4 00 0 0 (5) (5) (5) (5) 55 00 00 00 00 00 (4). (4) 5 0 0 0 0 0 (5) 3 0 0 2 0 0 (4) 4 55 4 ( ) Number in parentheses indicates number of tissues examined. Data listed as number affected. SL 068169